Qian Shenglei - Net Worth and Insider Trading

Qian Shenglei Net Worth

The estimated net worth of Qian Shenglei is at least $5 Million dollars as of 2024-09-24. Qian Shenglei is the 2101 Beneficial owner of New Ray Medicine International Holding Ltd and owns about 119,752,000 shares of New Ray Medicine International Holding Ltd (HKSE:06108) stock worth over $5 Million. Details can be seen in Qian Shenglei's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Qian Shenglei has not made any transactions after 2022-11-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Qian Shenglei

Qian Shenglei Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Qian Shenglei owns 1 companies in total, including New Ray Medicine International Holding Ltd (HKSE:06108) .

Click here to see the complete history of Qian Shenglei’s form 4 insider trades.

Insider Ownership Summary of Qian Shenglei

Ticker	Comapny	Transaction Date	Type of Owner
HKSE:06108	New Ray Medicine International Holding Ltd	2022-11-30	2101 Beneficial owner

Qian Shenglei Latest Holdings Summary

Qian Shenglei currently owns a total of 1 stock. Qian Shenglei owns 119,752,000 shares of New Ray Medicine International Holding Ltd (HKSE:06108) as of November 30, 2022, with a value of $5 Million.

Latest Holdings of Qian Shenglei

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:06108	New Ray Medicine International Holding Ltd	2022-11-30	119,752,000	0.04	4,670,328

Holding Weightings of Qian Shenglei

Qian Shenglei Form 4 Trading Tracker

According to the SEC Form 4 filings, Qian Shenglei has made a total of 2 transactions in New Ray Medicine International Holding Ltd (HKSE:06108) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in New Ray Medicine International Holding Ltd is the sale of 40,000,000 shares on November 30, 2022, which brought Qian Shenglei around $4 Million.

Insider Trading History of Qian Shenglei

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Qian Shenglei Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Qian Shenglei Ownership Network

Ownership Network List of Qian Shenglei

No Data

Ownership Network Relation of Qian Shenglei

Qian Shenglei Owned Company Details

What does New Ray Medicine International Holding Ltd do?

Who are the key executives at New Ray Medicine International Holding Ltd?

Qian Shenglei is the 2101 Beneficial owner of New Ray Medicine International Holding Ltd. Other key executives at New Ray Medicine International Holding Ltd include Dai Xiaosong , Eagle Amber Holdings Limited , and 2201 Interest of corporation controlled by you Chu Xueping .

New Ray Medicine International Holding Ltd (HKSE:06108) Insider Trades Summary

Over the past 18 months, Qian Shenglei made no insider transaction in New Ray Medicine International Holding Ltd (HKSE:06108). Other recent insider transactions involving New Ray Medicine International Holding Ltd (HKSE:06108) include a net sale of 0 shares made by Chu Xueping , a net sale of 0 shares made by Eagle Amber Holdings Limited , and a net sale of 0 shares made by Dai Xiaosong .

In summary, during the past 3 months, insiders sold 0 shares of New Ray Medicine International Holding Ltd (HKSE:06108) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of New Ray Medicine International Holding Ltd (HKSE:06108) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

New Ray Medicine International Holding Ltd (HKSE:06108)'s detailed insider trading history can be found in Insider Trading Tracker table.

New Ray Medicine International Holding Ltd Insider Transactions

No Available Data

Qian Shenglei Mailing Address

Above is the net worth, insider trading, and ownership report for Qian Shenglei. Currently GuruFocus does not have mailing address information for Qian Shenglei.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.